Cohbar Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.36 |
Market Cap |
$71.45 M |
Shares Outstanding |
42.78 M |
Public Float |
28.53 M |
Address |
1455 Adams Drive Pasadena California 94025 United States |
Employees | - |
Website | http://www.cohbar.com |
Updated | 07/08/2019 |
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA. |